| 國家衛生研究院 |
2023-12-21 |
Dose of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding in older adults
|
Li, YH;Hang, LW;Muo, CH;Chen, SJ;Chen, PC |
| 中國醫藥大學 |
2012-08 |
Dose point kernel simulation for monoenergetic electrons and radionuclides using Monte Carlo Techniques
|
吳杰(Jay Wu);(Y. L. Liu);(S. J. Chang);(M. M. Chao);(S. Y. Tsai);(D. E. Huang) |
| 臺大學術典藏 |
2022-07-15T06:43:56Z |
Dose Rate Effect of 125I Irradiation on Normal Rabbit Eyes and Experimental Choroidal Melanoma
|
CHUNG-MAY YANG; Olsen K.R.; Schwade J.G.; Houdek P.V.; Markoe A.M.; Pisciotta V.; Wu X. |
| 中國醫藥大學 |
1995-03-31 |
Dose reconstruction for chronic low dose ionizing radiation exposure residents
|
黃彬芳(Bing-Fang Hwang); (Tsau CJ); (Wang LA); (Chang WP)*; (Hwang JS.) |
| 中國醫藥大學 |
1995-10-15 |
Dose reconstruction forγ-irradiation overexposure from residential buildings in Taiwan
|
(Chang WP)*; (Hwang JS); (Chan CC); (Wang LA); 黃彬芳(Bing-Fang Hwang); (Tsau CJ); (Cardarelli Jr.) |
| 臺大學術典藏 |
2018-09-10T05:10:36Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan, S.-C. and Hsieh, S.-M. and Hung, C.-C. and Huang, P.-F. and Chen, M.-Y. and Chang, S.-C.; SZU-MIN HSIEH |
| 臺大學術典藏 |
2018-09-10T05:14:27Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan, S.-C. and Hsieh, S.-M. and Hung, C.-C. and Huang, P.-F. and Chen, M.-Y. and Chang, S.-C.; SUNG-CHING PAN |
| 臺大學術典藏 |
2018-09-10T05:14:32Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan, S.-C. and Hsieh, S.-M. and Hung, C.-C. and Huang, P.-F. and Chen, M.-Y. and Chang, S.-C.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-09-30T02:30:20Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Sung-Ching Pan;Hsieh S.-M.;Hung C.-C.;Huang P.-F.;Chen M.-Y.;Chang S.-C.; SUNG-CHING PAN; Hsieh S.-M.; Hung C.-C.; Huang P.-F.; Chen M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2005 |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Chang S.-C.; Pan S.-C.;Hsieh S.-M.;Chien-Ching Hung;Huang P.-F.;Chen M.-Y.;Chang S.-C.; Pan S.-C.; Hsieh S.-M.; CHIEN-CHING HUNG; Huang P.-F.; Chen M.-Y. |
| 臺大學術典藏 |
2005 |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Chang S.-C.; Huang P.-F.; Chen M.-Y.; SZU-MIN HSIEH; Hung C.-C.; Pan S.-C.; Pan S.-C.;Szu-Min Hsieh;Hung C.-C.;Huang P.-F.;Chen M.-Y.;Chang S.-C. |
| 臺大學術典藏 |
2020-12-30T02:44:25Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan S.-C.;Hsieh S.-M.;Hung C.-C.;Huang P.-F.;Chen M.-Y.;Shan-Chwen Chang; Pan S.-C.; Hsieh S.-M.; Hung C.-C.; Huang P.-F.; Chen M.-Y.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-12-01T02:30:18Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan S.-C.; Hsieh S.-M.; CHIEN-CHING HUNG; Huang P.-F.; Chen M.-Y.; Chang S.-C. |
| 高雄醫學大學 |
2009 |
Dose reduction of parotid gland in treatment of Nasopharyngeal cancer with Helical Tomotherapy
|
連熙隆;方本詞;黃志仁;黃旼儀;白立柱;李惠娥 |
| 淡江大學 |
2008-07 |
Dose Self-efficacy Affect Career Commitment? Evidence from the Foodservice Industry
|
牛涵錚; Chen, Li-chan; Wang, Yau-de; Yang, chyan |
| 亞洲大學 |
2012 |
Dose the Purchasing of Directors’ Liability Insurance Enhance or Mitigate a Firm’s Overinvestment
|
Chen, Chia-Wei;Lin, Pin-Shiuan |
| 國立臺灣大學 |
1993 |
Dose Titration Study of Isradipine in Chinese Patients with Mild to Moderate Essential Hypertension
|
廖朝崧; 陳明豐; Chen, C. C.; Chen, W. J.; Wu, C. C.; 李源德; 廖朝崧; 陳明豐; Chen, C. C.; Chen, W. J.; Wu, C. C.; Lee, Yuang-Teh |
| 臺大學術典藏 |
2020-02-27T07:43:51Z |
Dose titration study of isradipine in Chinese patients with mild to moderate essential hypertension
|
Chen C.-C.; WEN-JONE CHEN; Wu C.-C.; Liau C.-S.; Lee Y.-T.; Lee Y.-T.;Liau C.-S.;Wu C.-C.;WEN-JONE CHEN;Chen C.-C.;Chen M.-F.; Chen M.-F. |
| 臺大學術典藏 |
2020-03-04T09:03:38Z |
Dose titration study of isradipine in Chinese patients with mild to moderate essential hypertension
|
Chen M.-F.; Chen C.-C.; Chen W.-J.; CHAU-CHUNG WU; Liau C.-S.; Lee Y.-T. |
| 臺大學術典藏 |
1993 |
Dose titration study of isradipine in Chinese patients with mild to moderate essential hypertension
|
Chen M.-F.; Chen C.-C.; WEN-JONE CHEN; Wu C.-C.; Liau C.-S.; Lee Y.-T. |
| 國立臺灣大學 |
1993 |
Dose Titration Study of Isradipine in Chinese Patients with Mild to Morderate Essential Hypertension
|
Chen, M. F.; Chen, C. C.; 陳維昭; 吳造中; Liau, C. S.; Lee, Y. T.; Chen, M. F.; Chen, C. C.; Chen, Wei-Jao; Wu, Chau-Chung; Liau, C. S.; Lee, Y. T. |
| 國立政治大學 |
2010-01-29 |
Dose transformational leadership facilitate SBU innovation? The moderating roles of SBU culture and incentive compensation
|
林月雲; 陳怡靜; Mavis Yi-Ching Chen; Carol Yeh-Yun Lin |
| 中國醫藥大學 |
2008-10-25 |
Dose using calcium phosphate bone cement contribute to the maintainence of alignment in patients with distal radial fracture treated with CREF?
|
林承志(Cheng-Jyh Lin); 許弘昌(Horng-Chaung Hsu); 洪誌鴻(Chi-Horng Horng) |
| 臺大學術典藏 |
2008 |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Kuo S.-H.; Lien H.-C.; You S.-L.; Lu Y.-S.; Lin C.-H.; Chen T.-Z.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2021-07-28T06:46:58Z |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Kuo S.-H.; Lien H.-C.; You S.-L.; Lu Y.-S.; CHING-HUNG LIN; Chen T.-Z.; Huang C.-S. |
